Evekeo ODT™ (amphetamine sulfate) – New drug approval
January 30, 2019 - The FDA approved Arbor Pharmaceuticals’ Evekeo ODT (amphetamine sulfate) orally disintegrating tablets, for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age.
Download PDF
